Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 13.89
-0.11 (-0.80%)
Mar 6, 2026, 1:00 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 17.50 million as of March 6, 2026. Its market cap has increased by 126.60% in one year.
Market Cap
17.50M
Enterprise Value
17.64M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.89
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 17.50M, a decrease of -35.85%. That is a compound annual growth rate of -5.26%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 21.40M |
| Aptamer Group | 22.92M |
| SkinBioTherapeutics | 24.78M |
| Arecor Therapeutics | 27.18M |
| Oxford BioDynamics | 10.73M |
| Poolbeg Pharma | 28.91M |
| Genflow Biosciences | 9.38M |
| ImmuPharma | 34.94M |